deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT02662504

Intrapleural Photodynamic Therapy in a Multimodal Treatment for Patients With Malignant Pleural Mesothelioma (MesoPDT)

Pilot Study of the Feasibility of Intrapleural Photodynamic Therapy in a Multimodal Treatment Combining Extended Pleurectomy/Decortication, Adjuvant Chemotherapy and Prophylactic Radiotherapy in Patients With Malignant Pleural Mesothelioma

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France

Updated 8 times since 2017 Last updated: Feb 2, 2026 Started: Jan 16, 2016 Primary completion: Mar 12, 2018 Completion: Mar 13, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Malignant Pleural Mesothelioma, this trial is completed. The trial is conducted by Institut National de la Santé Et de la Recherche Médicale, France and has accumulated 8 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotRecruiting~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshotRecruiting~Jul 2018 – ~Jan 2021 · 30 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Feb 2026 · 17 months · monthly snapshotCompleted~Feb 2026 – present · 5 months · monthly snapshotCompleted

Change History

8 versions recorded
  1. Feb 2026 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Feb 2026 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  5. Jul 2018 — Jan 2021 [monthly]

    Completed PHASE2

    Status: RecruitingCompleted

Show 3 earlier versions
  1. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE2

  2. Feb 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  3. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Institut National de la Santé Et de la Recherche Médicale, France
  • Région Nord-Pas de Calais, France
  • University Hospital, Lille
  • University of Pennsylvania
Data source: University Hospital, Lille

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations